Prof. Gideon Gross : Immunology
Developing a novel model system to target insulin reactive CD8 T cells
Scott, G. S., Fishman, S., Margalit, A., Siew L. K., Chapman, S., Wen, L., Gross, G. & Wong, F. S.
2008
,
Ann. N.Y. Acad. Sci. 2008 Volume 1150, Pages 54?58
Targeting tumor-associated antigens to the MHC class I presentation pathway
G. Gross; A. Margalit
2007
,
Endocrine, Metabolic and Immune Disorders - Drug Targets 2007 Volume 7 Issue 2 Pages 99-109
Induction of anti-tumor immunity by CTL epitopes genetically linked to membrane- anchored beta2 microglobulin
Margalit, A., Migalovich Sheikhet, H., Carmi, Y., Berko, D., Tzehoval, E., Eisenbach, L. & Gross, G.
2006
,
J. Immunol. 2006 Volume 176 Pages 217-224
HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1
R. Meyuhas; H. Noy; D. C. Montefiori; G. Denisova; J. M. Gershoni; G. Gross
2005
,
Molecular Immunology 2005 Volume 42 Issue 9 Pages 1099-1109
Membrane-anchored β2-microglobulin stabilizes a highly receptive state of MHC class I molecules
D. Berko; Y. Carmi; G. Cafri; S. Ben-Zaken; H. M. Sheikhet; E. Tzehoval; L. Eisenbach; A. Margalit; G. Gross
2005
,
Journal of Immunology 2005 Volume 174 Issue 4 Pages 2116-2123
In-cell generation of antibody single-chain Fv transcripts by targeted RNA trans-splicing
J. Schlesinger; D. Arama; H. Noy; M. Dagash; P. Belinky; G. Gross
2003
,
Journal of Immunological Methods 2003 Volume 282 Pages 175-186
The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1
D. Enshell-Seijffers; D. Denisov; B. Groisman; L. Smelyanski; R. Meyuhas; G. Gross; G. Denisova; J. M. Gershoni
2003
,
Journal of Molecular Biology 2003 Volume 334 Issue 1 Pages 87-101
Chimeric ?2 microglobulin/CD3?polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8+ T cells
A. Margalit; S. Fishman; D. Berko; J. Engberg; G. Gross
2003
,
International Immunology 2003 Volume 15 Issue 11 Pages 1379-1387
Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens
J. Pitcovski; B. Gutter; G. Gallili; M. Goldway; B. Perelman; G. Gross; S. Krispel; M. Barbakov; A. Michael
2003
,
Vaccine 2003 Volume 21 Issue 32 Pages 4736-4743
Antibody expression from the core region of the human IgH locus reconstructed in transgenic mice using bacteriophage P1 clones
S. D. Wagner; G. Gross; G. P. Cook; S. L. Davies; M. S. Neuberger
1996
,
Genomics 1996 Volume 35 Issue 3 Pages 405-414
The T-body approach: Potential for cancer immunotherapy
Z. Eshhar; N. Bach; C. J. Fitzer-Attas; G. Gross; J. Lustgarten; T. Waks; D. G. Schindler
1996
,
Springer Seminars in Immunopathology 1996 Volume 18 Issue 2 Pages 199-209
T-bodies: Chimeric T-cell receptors with antibody-type specificity
Z. Eshhar; G. Gross; T. Waks; J. Lustgarten; N. Bach; A. Ratner; J. Treisman; D. G. Schindler
1995
,
Methods: A Companion to Methods in Enzymology 1995 Volume 8 Issue 2 Pages 133-142
Chimaeric T-cell receptors specific to a B-lymphoma idiotype: A model for tumour immunotherapy
G. Gross; S. Levy; R. Levy; T. Waks; Z. Eshhar
1995
,
Biochemical Society Transactions 1995 Volume 23 Issue 4 Pages 1079-1082
Anti-leucocyte function-associated antigen-1 antibodies inhibit T-cell activation following low-avidity and adhesion-independent interactions
G. Gorochov; G. Gross; T. Waks; Z. Eshhar
1993
,
Immunology 1993 Volume 79 Issue 4 Pages 548-555
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor γ chain
P. Hwu; G. E. Shafer; J. Treisman; D. G. Schindler; G. Gross; R. Cowherd; S. A. Rosenberg; Z. Eshhar
1993
,
Journal of Experimental Medicine 1993 Volume 178 Issue 1 Pages 361-366
Modifying the specificity of T cells using chimeric Ig/TCR genes.
Eshhar, Z., Gross G. & Treisman J
1993
,
In Tumour Immunobiology: A Practical Approach ,1993, G. Gallagher, R. C. Rees & C. W. Reynolds, Ed. ,Oxford University Press , Pages 345-368.
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors
Z. Eshhar; T. Waks; G. Gross; D. G. Schindler
1993
,
Proceedings of the National Academy of Sciences of the United States of America 1993 Volume 90 Issue 2 Pages 720-724
Endowing T cells with antibody specificity using chimeric T cell receptors
G. Gross; Z. Eshhar
1992
,
FASEB Journal 1992 Volume 6 Issue 15 Pages 3370-3378
Functional assembly of chimeric T-cell receptor chains
G. Gorochov; J. Lustgarten; T. Waks; G. Gross; Z. Eshhar
1992
,
International Journal of Cancer 1992 Issue SUPPL. 7 Pages 53-57
Chimeric T cell receptor which incorporates the anti-tumour specificity of a monoclonal antibody with the cytolytic activity of T cells: a model system for immunotherapeutical approach
Z. Eshhar; G. Gross
1990
,
The British journal of cancer. Supplement 1990 Volume 10 Pages 27-29
Expression of chimeric antibody/T cell receptor genes as functional receptor molecules in human and mouse T cells.
Gorochov, G., Gross, G., Waks, T. & Eshhar, Z.
1990
,
Wiley-Liss Inc. New York, N.Y. ,1990
Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity
G. Gross; T. Waks; Z. Eshhar
1989
,
Proceedings of the National Academy of Sciences of the United States of America 1989 Volume 86 Issue 24 Pages 10024-10028
Functional expression of a chimeric T cell receptor with an antibody binding site.
Gross, G., Waks, T. & Eshhar, Z.
1989
,
Alan R. Liss Inc. New York, USA ,1989
Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity
G. Gross; G. Gorochov; T. Waks; Z. Eshhar
1989
,
Transplantation Proceedings 1989 Volume 21 Issue 1 I Pages 127-130
Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor
S. Luria; G. Gross; M. Horowitz; D. Givol
1987
,
EMBO Journal 1987 Volume 6 Issue 11 Pages 3307-3312